Listed

Pediatrix Medical Group, Inc.

MDNYSECIK 893949HealthcareFiscal year ends Dec 31

Reports and events: 259 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Pediatrix Medical Group, Inc., Reports and events
FiledFormWhat it isAccession number
2020-05-1216:43 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001193125-20-140531
2020-05-0716:26 ET10-QQuarterly reportPeriod 2020-03-310001193125-20-136311
2020-05-0706:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-135547
2020-05-0609:17 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-134447
2020-04-2817:16 ET10-K/AAnnual report, amendedPeriod 2019-12-310001193125-20-123354
2020-04-0716:15 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-100475
2020-03-2506:53 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-20-012671
2020-03-0916:30 ET8-K8.01 Other events0001193125-20-067220
2020-03-0217:23 ETSC 13D/AOwnership report, active investor, amended0000921895-20-000633
2020-02-2006:53 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-042625
2020-02-2006:51 ET10-KAnnual reportPeriod 2019-12-310001193125-20-042622
2020-02-1317:29 ETSC 13DOwnership report, active investor0000921895-20-000442
2020-01-1517:24 ET8-K5.02 Departure or appointment of officers or directors0001193125-20-008166
2019-12-1106:06 ET8-K8.01 Other events0001193125-19-310607
2019-11-0106:54 ET10-QQuarterly reportPeriod 2019-09-300001193125-19-281135
2019-11-0106:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-281131
2019-10-1006:50 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-265496
2019-08-0116:30 ET10-QQuarterly reportPeriod 2019-06-300001193125-19-210927
2019-08-0106:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-209632
2019-07-0816:06 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-190533
2019-06-2817:23 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-186223
2019-05-1717:24 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-19-150702
2019-05-0216:23 ET10-QQuarterly reportPeriod 2019-03-310001193125-19-135054
2019-05-0206:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-133788
2019-03-2916:30 ETDEF 14AProxy statementPeriod 2019-05-160001193125-19-092753
2019-03-2916:21 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-19-092716
2019-03-2806:52 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-089230
2019-02-2117:00 ET8-K2.03 New direct financial obligation0001193125-19-047118
2019-02-1416:21 ET10-KAnnual reportPeriod 2018-12-310001193125-19-040891
2019-02-0706:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-030161
2018-11-2616:50 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-18-333998
2018-11-1317:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-18-325590
2018-11-0616:55 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-18-319651
2018-11-0116:21 ET10-QQuarterly reportPeriod 2018-09-300001193125-18-315785
2018-11-0106:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-314709
2018-09-2017:23 ETSC 13D/AOwnership report, active investor, amended0000902664-18-003505
2018-09-0416:38 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-266272
2018-08-2817:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-260694
2018-08-0216:30 ET10-QQuarterly reportPeriod 2018-06-300001193125-18-236651
2018-08-0206:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-235580
2018-05-1717:06 ET8-K5.07 Shareholder vote results0001193125-18-166664
2018-05-0416:28 ET10-QQuarterly reportPeriod 2018-03-310001193125-18-152850
2018-04-3017:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-143735
2018-03-2316:31 ETDEF 14AProxy statementPeriod 2018-05-160001193125-18-094194
2018-03-0816:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-18-075175
2018-02-1416:54 ET10-KAnnual reportPeriod 2017-12-310001193125-18-045748
2018-02-0806:51 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-035400
2017-11-1608:30 ETSC 13DOwnership report, active investor0000902664-17-004368
2017-11-0116:20 ET10-QQuarterly reportPeriod 2017-09-300001193125-17-329442
2017-11-0106:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-328167

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.